The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Deal-starved banks lined up to make concessions to get a slice of Europe’s biggest buyout debt deal last year. They also put ...

Sanofi in exclusive talks with CD&R over sale of $17 billion Opella October 21, 2024 French luxury giant LVMH reported a 3% fall in third-quarter sales on Tuesday, undershooting estimates in its ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

In 2025, Sanofi will receive a cash consideration in the high single-digits in billions in euros from the Opella transaction at the earliest in Q2 while retaining a significant stake in the ...

Net sales for the quarter were EUR 11.4 billion, or 5.4% growth after excluding Opella, the consumer healthcare franchise. Sanofi issued sales growth guidance for 2025 of mid-to-high-single digits ...

Sanofi has plans to separate its Consumer Healthcare [“CHC”] unit through the creation of a publicly listed entity headquartered in Paris called Opella. Sanofi intends to sell a controlling ...

The sale of Sanofi's controlling stake in consumer health business Opella is expected to close in the second quarter at the earliest, completing its transition into a pure-play drug and vaccine ...

Sanofi also said it would launch a buyback of up to 5 billion euros ($5.21 billion) in 2025, stemming from plans to sell a controlling stake in its Opella consumer health business, which the ...

The sale of Sanofi's controlling stake in consumer health business Opella is expected to close in the second quarter at the earliest, completing its transition into a pure-play drug and vaccine ...